Answers are grounded in this paper and cite their sources.
A five-step synthesis of an array of N-aryl-3-alkylidenepyrrolinones, which are potential Niemann-Pick type C (NPC) disease therapeutics, is described. The synthetic route allows for the production of analogues, including photoaffinity and biotinylated derivatives. Compound 1a increased esterification by acyl-coenzyme A:cholesteryl acyltransferase in NPC1 mutant cells. It also decreased LDL uptake and increased cholesterol efflux in both NPC1-deficient and normal cells.
No takes yet. Share an insight, caveat, or question.
Cosner et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: